Trial Profile
A trial to assess 2 years of therapy with tocilizumab in patients with rheumatoid arthritis who may be receiving concomitant methotrexate and prednisolone
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Aug 2015
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 09 Aug 2015 New trial record
- 10 Jun 2015 Results presented at the 16th Annual Congress of the European League Against Rheumatism.